J BREAST CANC 2019 10.4048/jbc.2019.22.e17
Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
Jang1, Y; Cho, EY; Cho, SY

ONCOL LETT 2019 10.3892/ol.2018.9754
Clinical features and prognosis of breast cancer with gastric metastasis
Hong1, J; Kim, Y; Cho, J; Lim, SW; Park, SE; Kim, HK; Lee, H; Cho, SY; Kim, JY; Ahn, JS; Im, YH; Park, YH

PLoS One 2019 10.1371/journal.pone.0212309
Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

ANTICANCER RES 2019 10.21873/anticanres.13121
Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel BRAF Mutation
Bae1, GE; Yoon, N; Cho, EY; Kim, HS; Cho, SY

BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

J BREAST CANC 2018 10.4048/jbc.2018.21.e48
PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis
Seo1, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY

BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Oncoimmunology 2018 10.1080/2162402X.2018.1466768
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer
Park1, SE; Park, K; Lee, E; Kim, JY; Ahn, JS; Im, YH; Lee, C; Jung, H; Cho, SY; Park, WY; Cristescu, R; Park, YH

CLIN CANCER RES 2018 10.1158/1078-0432.CCR-17-0866
CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug
Chung1, MK; Jung, YH; Lee, JK; Cho, SY; Murillo-Sauca, O; Uppaluri, R; Shin, JH; Sunwoo, JB

SCI REP-UK 2018 10.1038/s41598-017-18642-x
Droplet digital PCR-based &ITEGFR &ITmutation detection with an internal quality control index to determine the quality of DNA
Kim1, SS; Choi, HJ; Kim, JJ; Kim, MS; Lee, IS; Byun, B; Jia, LN; Oh, MR; Moon, Y; Parka, S; Choi, JS; Chae, SW; Nam, BH; Kim, JS; Kim, J; Min, BS; Lee, JS; Won, JK; Cho, S; Choi, YL; Shin, YK

Ultrasound Q 2017 10.1097/RUQ.0000000000000307
Lymphoma Involving Skin and Subcutaneous Fat of the Breast: Two Cases
Kwon1, M; Ko, EY; Han, BK; Ko, YH; Cho, EY; Cho, SY; Kim, SY

J BREAST CANC 2017 10.4048/jbc.2017.20.3.286
NanoString nCounter (R) Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry
Hyeon1, J; Cho, SY; Hong, ME; Kang, SY; Doe, I; Im, YH; Cho, EY

Sci Rep. 2017 Mar 28;7:45554. doi: 10.1038/srep45554.
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
Gong G11, Kwon MJ2,3, Han J4, Lee HJ1, Lee SK5, Lee JE5, Lee SH6, Park S7, Choi JS7, Cho SY8, Ahn SH9, Lee JW9, Cho SR4, Moon Y4, Nam BH10, Nam SJ5, Choi YL8,11,12, Shin YK7,13,14.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746
Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy
Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

Breast Cancer Res Treat. 2016 Dec;160(3):475-489. doi: 10.1007/s10549-016-4008-4. Epub 2016 Oct 11.
Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems
Choi M11, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.

J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23.
Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
Seong M11, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.

Acta Radiol. 2016 May;57(5):521-8. doi: 10.1177/0284185115590287. Epub 2015 Jun 12.
Shear-wave elastography in invasive ductal carcinoma: correlation between quantitative maximum elasticity value and detailed pathological findings
Cho EY11, Ko ES2, Han BK3, Kim RB4, Cho S1, Choi JS3, Hahn SY3.

Surgery. 2015 Jan;157(1):111-8. doi: 10.1016/j.surg.2014.05.023. Epub 2014 Oct 14.
Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia
Cho SY11, Lee TH2, Ku YH3, Kim HI3, Lee GH4, Kim MJ5.

Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.
Invasive Paget disease of the breast: 20 years of experience at a single institution
Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

Gut Liver. 2014 Nov;8(6):648-54. doi: 10.5009/gnl13406. Epub 2014 Oct 7.
High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma
Ha SY11, Song DH1, Lee JJ1, Lee HW1, Cho SY1, Park CK1.

Gut Liver. 2014 Nov;8(6):662-8. doi: 10.5009/gnl13392. Epub 2014 Nov 15.
High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
Lee B11, Ha SY1, Song DH1, Lee HW1, Cho SY1, Park CK1.

Med Oncol. 2014 Nov;31(11):236. doi: 10.1007/s12032-014-0236-9. Epub 2014 Sep 30.
The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma
Cho SY11, Ha SY, Huang SM, Kim JH, Kang MS, Yoo HY, Kim HH, Park CK, Um SH, Kim KH, Kim SH.